UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000039537
Receipt No. R000045087
Scientific Title An observation study of perioperative nintedanib therapy in patients with non-small-cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)
Date of disclosure of the study information 2020/03/01
Last modified on 2020/08/20 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title An observation study of perioperative nintedanib therapy in patients with non-small-cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)
Acronym Nintedanib therapy in patients with NSCLC with IPF
Scientific Title An observation study of perioperative nintedanib therapy in patients with non-small-cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)
Scientific Title:Acronym Nintedanib therapy in patients with NSCLC with IPF
Region
Japan

Condition
Condition non-small-cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)
Classification by specialty
Chest surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Safety
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Safety
Key secondary outcomes Postoperative exacerbation-free time of IPF
2-year survival rate

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Non-small-cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)
Clinical stage I-IIIA
Patient who has operative indication
Key exclusion criteria Past history of chest surgery
Alternative prior treatment for IPF
Past history of chemotherapy or radiation for chest
Administration of oxygen therapy
Infectious disease requiring treatment
Target sample size 23

Research contact person
Name of lead principal investigator
1st name Hidetaka
Middle name
Last name Uramoto
Organization Kanazawa Medical University
Division name Thoracic Surgery
Zip code 920-0293
Address 1-1 daigaku, Uchinada, Ishikawa Japan
TEL 0762862211
Email hidetaka@kanazawa-med.ac.jp

Public contact
Name of contact person
1st name Nozomu
Middle name
Last name Motono
Organization Kanazawa Medical University
Division name Thoracic Surgery
Zip code 920-0293
Address 1-1 daigaku, Uchinada, Ishikawa, Japan
TEL 0762862211
Homepage URL
Email motono@kanazawa-med.ac.jp

Sponsor
Institute Kanazawa Medical University
Institute
Department

Funding Source
Organization Kanazawa Medical University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The Institutional Review Boards of Kanazawa Medical University
Address 1-1 daigaku, Uchinada, Ishikawa, Japan
Tel 0762188346
Email tiken@kanazawa-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 03 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 1
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2020 Year 02 Month 04 Day
Date of IRB
2020 Year 05 Month 01 Day
Anticipated trial start date
2020 Year 05 Month 02 Day
Last follow-up date
2020 Year 08 Month 20 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Observation study

Management information
Registered date
2020 Year 02 Month 19 Day
Last modified on
2020 Year 08 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000045087